Get access

Development of Fluorescent Glucose Bioprobes and Their Application on Real-Time and Quantitative Monitoring of Glucose Uptake in Living Cells

Authors

  • Hyang Yeon Lee,

    1. Department of Chemistry, Seoul National University, Seoul 151-747 (Korea), Fax: (+82) 28844025
    Search for more papers by this author
  • Jae Jeong Lee,

    1. Department of Chemistry, Seoul National University, Seoul 151-747 (Korea), Fax: (+82) 28844025
    Search for more papers by this author
  • Jongmin Park,

    1. Department of Chemistry, Seoul National University, Seoul 151-747 (Korea), Fax: (+82) 28844025
    Search for more papers by this author
  • Prof. Seung Bum Park

    Corresponding author
    1. Department of Chemistry, Seoul National University, Seoul 151-747 (Korea), Fax: (+82) 28844025
    2. Department of Biophysics and Chemical Biology, Seoul National University, Seoul 151-747 (Korea)
    • Department of Chemistry, Seoul National University, Seoul 151-747 (Korea), Fax: (+82) 28844025
    Search for more papers by this author

Abstract

We developed a novel fluorescent glucose bioprobe, GB2-Cy3, for the real-time and quantitative monitoring of glucose uptake in living cells. We synthesized a series of fluorescent glucose analogues by adding Cy3 fluorophores to the α-anomeric position of D-glucose through various linkers. Systematic and quantitative analysis of these Cy3-labeled glucose analogues revealed that GB2-Cy3 was the ideal fluorescent glucose bioprobe. The cellular uptake of this probe competed with the cellular uptake of D-glucose in the media and was mediated by a glucose-specific transport system, and not by passive diffusion. Flow cytometry and fluorescence microscopy analyses revealed that GB2-Cy3 is ten times more sensitive than 2-NBDG, a leading fluorescent glucose bioprobe. GB2-Cy3 can also be utilized for the quantitative flow cytometry monitoring of glucose uptake in metabolically active C2C12 myocytes under various treatment conditions. As opposed to a glucose uptake assay performed by using radioisotope-labeled deoxy-D-glucose and a scintillation counter, GB2-Cy3 allows the real-time monitoring of glucose uptake in living cells under various experimental conditions by using fluorescence microscopy or confocal laser scanning microscopy (CLSM). Therefore, we believe that GB2-Cy3 can be utilized in high-content screening (HCS) for the discovery of novel therapeutic agents and for making significant advances in biomedical studies and diagnosis of various diseases, especially metabolic diseases.

Get access to the full text of this article

Ancillary